Zivo Bioscience Inc (QB) (ZIVO) 시세

A bunch of nothing. Reads like it was written by AI.

New 10k out.

How is ZIVO blowing this opportunity so bad? Mind boggling how they are not all over outlets discussing their natural therapeutic that reduces bird flu transmission.

“We’ve killed 166 million chickens. That’s why we have an egg crisis,” Kennedy told Fox’s Sean Hannity, adding that bird flu is not transmissible via eggs or food.

“Most of our scientists are against the culling operation. They think that we should be testing therapeutics on those flocks. They should isolate. You should let the disease go with them and identify the birds that survive, which are the birds that probably have a genetic inclination for immunity.”

Well,

I'd certainly like to see some good luck bestowed on ZIVO shareholders.

Those who didn't partake in the Weazel/Amigo wave surfing over the years have more or less lost their shirts and need a win ...... badly. With all the potential eyes on ZIVO right now ..... seems ripe for a buyout / license ..... hell it's literally been 20 years that I've known or met people that have owned ZIVO. Lotta very profitable swing trades to make money here but like I said, if you haven't been playing that game over the years, you are a long way from making money. So if there are more eyes than normal on this thing right now as we have been led to believe from the PRs ...... as a shareholder ... a deal can't happen fast enough .... but at same time it's mgmt's duty to work the process for the best deal for the company/shareholders. So if that means waiting longer .... I certainly don't like it given the time already passed ..... but more or less gotta do it. Sucks ... but it is what it is.

Someone decided to dump a few this afternoon and L2 setup not looking that favorable with 5 MMs lined up below this morning's opening bid of $19. Not a good look and coupled with the markets in turmoil due to the sillly ass political uncertainty that's been thrown into the mix ... .add "WHEN" anything for ZIVO ..... and not a good recipe for positive movement without some news.

Anyway .... I hope that you are right .... but "hope" isn't an investment strategy as we all know.
SHOW ME THE MONEY !

Amigo Mike

Its really nothing special but looking for some "luck of the Irish..." to land our way soon

Gwinner,

Just curious ...... what's special about "this week" ? Unless I have missed something I'm not sure there are any expectations for communications presently.

Do shareholders need an update ??? .... YES .... any communication is a plus and certainly anything with DEFINITIVE timelines.
Avian flu ... unfortunately last PR left door open on "WHEN" so who knows if started, inprogress, done, when ?
Coccidiosis ...... my preference is full bore get it done by end of month for license ...... but my opinion is new avian fly vertical may have shifted the timeline with the potential of more animal pharmas asking questions and potentially desiring to get into the mix. My guess is at least 2 very interested. A third possibly ... and maybe more. ZIVO has had at least 2 collaborations with 2 different major animal pharmas. One is definitely Zoetis (bovine mastitis). I do not know who did their own test on coccidiosis but given how that test was done, I'm guessing it is a pharma with a comprehensive coccidiosis disease mgmt program which I don't think is Zoetis. The timeline of news would seem it indicate another pharma jumped in on coccidiosis. Dunno who that one is either. And who knows who else is interested by avian flu results.

It would seem the largest number of industry eyes would be on ZIVO right now ...... a great time to entertain buyout offers. INFLAMMATION,INFLAMMATION,INFLAMMATION. GUT HEALTH ... guess what .... rooted in INFLAMMATION. There is no doubt in my mind the algae and it's derivatives regulate inflammation in the body. Therefore the verticals are many.

IMO, ideally the algae and its variants fit the best with a pharma with human and animal divisions ..... ya get both applications in one shot. That narrows the field of potential candidates but offers the most bang for the buck for a pharma with all the vertical options ... plus they can get into both human and animal ingredients markets as well. WIN WIN in my book for them. And ZIVO already done a large part of the legwork and filed patents. $500 million for both human and animal vertical options is cheap in my book. ($100/share fully diluted) The pharma can hit the ground running.

So it is difficult to ascertain WHERE exactly things stand. Who is involved. At what stage anything sits .... other than coccidiosis is at license stage.

Trading is thin and stagnant stock movement for now ..... so no indications there. No major selling although appears someone trying to offload several thousand shares recently.

The annual 10K is due shortly .... and of course .... is a PERFECT opportunity for Payne to provide more of a broad update across the board and VISION INTO THE FUTURE. But ZIVO has been relatively poor with those kinds of things. In the Dahl era that was mainly offered at annual shareholder meetings. But another year of tests and losses for shareholders.

Odds on update ? Personally I wasn't expecting anything this week and I am assuming delays due to more eyes on it and "1H" offered in Microcap conference update. JMHO.

Amigo Mike

Grandpa snoozed long enough now the market is a mess and Zivo less likely to get a deal or buyer. This is why you act quickly when there is opportunity, which requires more youthful and energetic leadership.

Okay, does Payne give a share holder update this week??
Where would Vegas put these odds at?
My WAG is 10% chance

Be careful what you wish for.

Newbies pumping stock isn't always a good thing. Need investors .... not one chasing 15 minute moves in the stock. The is a ton of trash out there in the markets.

And .... ZIVO has too few shares at this point for institutions to have much interest.

So interesting spot. Need license and revenues and vision for the future.

Amigo Mike

Amigo, I figured we would have been at least picked up by other posters/followers who would have organically spread the word about Zivo and stock should have lifted to low 30's by now...but since that is NOT happening the ZIVO Board needs to keep pushing Payne or a Board member needs to step up and help push Payne to cut a deal instead of just cursory talk with animal pharma companies...Payne already has a boat load of cash so we need someone heavily vested and incented to get a deal done

Nasdaq would be ok .... but the company would need to be on much better financial footing BEFORE going to Nasdaq .... I.e. not needing a raise to go to Nasdaq or shortly thereafter. Wall Street scumbags that would handle a deal for ZIVO are bottom of the barrel and we don't want any part of them unless ZIVO is on much better footing.

So in my book no way I'd wanna see that before a license happens and revenues are coming in. They've basically raised money the last year and change with insiders and those close to them and given the middle finder salute to Wall Street. Those shares aren't going to see the light of day any time soon. The Wall Street scumbags rip investors and companies off and short sell into any raise to make even more and lie about it all day long. See 2023. Scumbags drove the stock into the ground.

Anyway, I understand the plan to license coccidiosis. I understand adding new verticals. Avian flu being a hot one. But I don't see a long term plan. I don't see moves being made to build the business more broadly and Payne isn't getting any younger. He's the industry guy ..... but after him there's nobody that appears to be an obvious replacement to move the company forward. Closest one would be director Cornell..

Anyway ..... I'm leaning towards a sale. If there are a number of global pharma eyes on it right now, then the subject should be brought up for consideration. I believe the applications are broad. But its a matter of these major pharmas coming to that conclusion and needing a reason to step to the plate and make an offer. ZIVOs done the years of tests. ZIVO has filed the patents. The baseline work is done. Time to cash it in. $250 million is the $50/share number on a fully diluted basis. There aren't that many shares out at this point but a buyout would include them. So if avian flu proves positive results again, don't know what the entire plan looks like there but it's worth more than $50 with that and all the other possibilities.

Amigo Mike

RFK critical of vaccinating poultry. Only grandpa and this incompetent board could screw up an opportunity like this. The village idiot would have this sold at $100 a share by now.

https://www.cbsnews.com/amp/news/rfk-jr-vaccinating-poultry-bird-flu-could-backfire/

Ya, cuz who wouldn't want another 'surprise' doubling of share count and 50% overnight haircut in price...again. 🤪

LOL.

Mike, spot on...there IS NO PLAN...hence why I have remained in my tiny position from the 1's with no adds. I agree with everything you state, but with no actual plan being worked...it's still 'hope' stage...which isn't gonna cut it (especially in current market environment).

I'm ALL FOR a sale at this point. I think most long-term ZIVO holders would be too. For lack of better words, gives them some money in their pocket and ends the 'misery' of having to watch them blow it month after month, year after year, for decades now...

Yeah I would like a straight sale too. But if they are going the license route and play the long game I would like them to uplist to Nasdaq first

Gwinner,

IMO, the advancement of bird flu situation and positive results have clouded the picture of WHEN a license, development agreement /JV, buyout situation might occur. As to communication, doesn't seem to matter who CEO is ... communication has always been the absolute worst. Taking advantage of social media ..... laughable here quite honestly.

There are sooooo many things I'd like to say here but it wouldn't really matter.

Bottomline with each passing day I'm more and more leaning towards Payne needing to explore the sale of the company.

We all know the algae strain works. Been tested ad nauseum over multiple verticals. ZIVO has identified the key molecule ... knows the mechanism of action ...... has developed the GRAS version and mass production techniques for large scale nutraceutical/ingredient possibilities. They know the key is regulation/modulation of the bodies inflammation response which is the underlying cause of NUMEROUS conditions in both human and animal health.

With the eyes of multiple pharmas are apparently on it ..... IMO .... it is time for a buyout. Payne should ask for offers .... get on offer out in the marketplace ..... say no .... and let the auction begin. I don't see a long term plan for the company. No succession plan. Can't spend years figuring out the next vertical to work on. Time to put this in the hands of a company that can do something with it.

I still stick with my opinion this is a $50 stock minimum with a coccidiosis license but if no one is looking who gonna care ? With Bird Flu. Hell that is a wild card that could bring massive attention and amounts of money. I don't know what that's worth but ... more than $50. All the potential verticals .... I've already said this thing is worth more than $1 billion .... but I don't see a plan to make that happen.

Amigo Mike

Look for another private placement to insiders soon so they can continue to lower their cost basis.

Zivo we know you read these threads...why are you not pushing your CEO to get a deal over the finish line?? Now is the time to strike. You couldn't have more bad shit coming from the poultry industry and its the industry you guys swim in....Get a deal done!

A billion being spent by the government to combat bird flu and Zivo silent. This could be a $50 or $100 stock with competent leadership who did not nap all day. Instead they are letting another opportunity pass us by.

https://www.npr.org/2025/02/28/g-s1-51270/egg-prices-usda-bird-flu

So,

Who offering on the stock so far today. Almost 8K on the best offers.
Dumb

Amigo Mike

More news this morning on how experts questioning the strategy of culling chickens to combat bird flu. It is not working and driving up egg prices. Wouldn’t it be great if we had a CEO who was able to articulate a message and get on podcasts to explain how there is a natural treatment that reduces transmission? Or a CEO who understands the power of social media to reach decision makers especially in this White House? Instead we have a grandpa with a “golden Rolodex” which has gotten zero exposure or funding partners. Time for new leadership who understands how to be a CEO in 2025.

Let’s hope grandpa wakes up and tells shareholders the plan for Zivo to be a part of this solution. We do not need another missed opportunity like Covid. Find a partner with money and let’s go.

“Agriculture Secretary Brooke Rollins said the plan includes a $500 million investment to strengthen biosecurity measures for farmers, $400 million in aid for those affected by avian flu, and $100 million for research into vaccines and therapeutics for U.S. chicken flocks. It also proposes reviewing and potentially rolling back certain state-level animal welfare regulations the administration considers restrictive.”

A whopping seven shares traded so far. Glad to see the Atlantic City conference was fruitful. Grandpa must have been as articulate as past presentations explain value proposition of investing in Zivo.

Market certainly is not impressed with the geriatric CEO. Handful of shares trading and trending down.

Defensive ?

Hardly. Just the facts. Comparing Zivo to Zoetis in the bird flu lane is just downright dumb.

You are the one throwing around terms like grandpa and geriatric. Ignorant comes to mind.

If ya don't know how long ZIVO been working specifically on coccidiosis .... not my problem. And isn't the right question. The fact is ... at this point in time they have garnered USDA oversight and have done all the necessary testing needed to gain a license with a company that can bring it to market .... all since Payne took over for Dahl. The "geriatric" seems to have a clue and has "attracted the interest of several global animals health companies". Not my words. Payne's words.

The question is whether they monetize it now .... or not ...... and that is all that matters.

Funny you ask me to answer question and you don't answer diddly .... its ok though. I already know the answers to the questions I ask.

Disengaged BoD?? Really ?? How much have you funded ZIVO over the last three years ? Cause they've provided millions in funding. And you have zero idea what they do or dont do for the company.

Amigo Mike

No need to get so defensive. Just answer the question:

How many years are we going on with coccidiosis testing and no revenue generating agreement?

What silly comparison / commentary on bird flu comparing to Zoetis.

Why don't you also add the timeline for Zoetis vaccine development eh ??? Zoetis been working on bird flu vaccines since ...... 2001 ..... and more recently since 2022 for current variant. And is piggybacking on previous approvals. Over 20 YEARS of work

You do realize that FEDERAL AGENCIES HAVE TO PROVIDE THEIR APPROVALS WHICH REQUIRES ALL THE APPROPRIATE TESTING AND MOUNTAINS OF PROOF .... I.E USDA/FDA.

Can you say. Duuuhhhhhhhhhh ???

https://news.zoetis.com/press-releases/press-release-details/2025/Zoetis-Receives-Conditional-License-from-USDA-for-Avian-Influenza-Vaccine-H5N2-Subtype-Killed-Virus/default.aspx

Zivo started in November / December.
Amigo Mike

Zoetis already out with a vaccine for bird flu and communicating with the public and investors while Payne spins in circles with more testing. The geriatric CEO and disengaged board doesn’t move fast enough. How many years are we going on with coccidiosis testing and no revenue generating agreement?

https://amp.cnn.com/cnn/2025/02/16/health/bird-flu-vaccine-zoetis-avian

Curious how you know mgmt is blowing this opportunity. The avian flu opportunity was announced literally just a few weeks ago. And a second trial is already in process.

This stuff doesnt happen overnight. And you've zero idea what this mgmt is or isn't doing with this particular product candidate outside of what has been announced.

What exactly is ZIVO mgmt supposed to be doing according to you ?

Amigo Mike

Rollins, during her confirmation hearing, indicated she’s been in touch with several Republican agriculture commissioners on the situation, which could be among the worst in decades. On Friday, she gave her first comments on the crisis.

"My very first briefing in my office last night was on this particular issue, on the avian bird flu. We are looking at every possible scenario to ensure that we are doing everything we can in a safe, secure manner, but also to ensure that Americans have the food that they need. And as a mom of four teenagers, actually, I fully understand and feel the pain of the cost of these eggs. So we will be announcing more in the coming days," she told reporters.

And we’ll see like 20 shares trade today. Terrible management blowing this opportunity like they did with Covid.

This is interesting....
Brooke Rollins new Agriculture Secretary comment about Bird Flu...
https://www.foxbusiness.com/video/6368840341112

She is making it a top priority

Mike check your email, Tx T.Ks Zivo is very interesting

News reports White House is focused on solutions to mitigate effects of bird flu to bring down price of eggs. Payne needs to step up or step down.

LOL,

You have a company that doesn't know what social media is. Been that way a long time. Don't see it changing under Payne. He's old school. That isn't his style and these guys don't have enough to talk about on a regular basis to keep a social media gig going anyway.

They do seem to find a way to shoot themselves in the foot whenever possible still ...... I don't get it .... like releasing last PR after 430PM on a Thursday evening.

I mean .... LOL .... DUH ..... you sent out a PR I assume you'd want people to read it. Pretty sure you can designate the exact time you want a PR to hit the wires. But everyone's pretty much gone home at 430 except those hanging around for earnings calls this time of year.

Just another reason I lean more each day towards selling the company. ZIVO cannot really "drive" anything the way it is currently set up. I don't see them proving out 1 vertical and then another and another. Too slow. No money. Not enough talent and totally reliant on external partners. The algae and its isolates in the proper hands can drive this thing into multiple verticals much faster than ZIVO. All these major pharmas both human and animal are looking for their next product candidates and ZIVO's got one. $100 is too cheap for buyout for potential verticals in human and animal health but the problem is ZIVO hasn't fully proven anything outside of coccidiosis. I think the Zoetis bovine mastitis tests were positive but I never squeezed out of Dahl why they didn't move forward. If I'm ZIVO and that is in a place that can be brought back to the forefront while "several" animal pharmas are looking .... I'd damn sure be pulling that out of the back room too and calling Kristen Peck ... who I know Payne knows .... and asking "wassup". Chickens, birds, dairy cattle .... all big problems.

Amigo Mike

ZIVO needs to pay someone $100k to just pump out press releases to TV Networks, Newspapers, Bloggers and any other media to let the F##king WORLD know what they got!!!!

The news about poultry is on daily!!!!!
And....no one knows about lil 'ol Zivo

This is now just crazy.......

I wonder who da genius is showing 5000 shares offered at $21.25.

Amigo Mike

Gwinner,

I'm not really surprised ...... ZIVO typically under promises and some day delivers. Timelines are a joke with this company and always have been.

Payne thus far hasn't really offered timelines for things although he did step out and say in the December PR he was expecting to land a license for coccidiosis by the end of the 1st qtr. So that's still 6-7 weeks away. But then there is this presentation given at the MicroCap conference ..... and it sez "1H" ...... i.e. end of June. (slide 14)

IMO ....... there has been some shifting in the timing and language being used. I think Payne offering >>>>>Catalyzed by encouraging findings from completed studies in avian influenza and coccidiosis, ZIVO has attracted interest from several global animal health companies seeking innovative, non-antibiotic solutions to combat disease transmission. This interest underscores the opportunity for ZIVO’s proprietary algal-derived compounds to play a role in improving poultry health and productivity.

Not surprised at all. Payne cannot execute and this board holds no one accountable.

I am truly shocked we don't have the "meaty" news that we all have counted on yet...
The main stream news is flooded with poultry news updates...Come on Zivo ......LETS GOOOOOOOOOOOOOOOOOO!

BlueMax,

Appreciate the note. Sorry to hear you've exited your position and certainly wish you the best with your future investments !

Amigo Mike

Poultry aricle today regarding avian flu.

https://www.wattagnet.com/broilers-turkeys/nutrition-feed/news/15737198/feeding-algae-to-poultry-could-halt-spread-of-low-path-ai
Amigo Mike

Amigo Mike, want to thank you for providing great observations all the time spent on summarizing various PR and other corporate publications. I got to meet Mike at an Annual Investor meeting in Detroit I think in 2013. Also to others who have offered interesting comments. After a very long time associated with ZIVO, going back to HEPI days, I have exited the position. I do hope that the latest information will be very positive for the company and the Investors!

Like I’ve been saying- incompetent investor relations. Why are they paying Tirth?

Interesting info in the PR ....

..... confirmation from Payne Catalyzed by encouraging findings from completed studies in avian influenza and coccidiosis, ZIVO has attracted interest from several global animal health companies seeking innovative, non-antibiotic solutions to combat disease transmission. "SEVERAL" is interesting word.

So in my book, we potentially have an "auction" and "first to act" type scenario here. This note also seems to indicate these companies are interested in both coccidiosis and avian fly applications.

SO BRING IT ON !!!
Amigo Mike

ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 06, 2025 04:36 PM Eastern Standard Time

TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces plans for a second collaborative study with the University of Delaware. This new study aims to further explore the potential applications of ZIVO's proprietary active ingredients in mitigating the spread of Low Pathogenicity Avian Influenza (LPAI) virus among poultry.

ZIVO’s previous study with the University of Delaware demonstrated a significant reduction in viral shedding and a delay in disease transmission among treated birds. This new study is designed to further optimize formulations and treatment protocols with the goal of enhancing the efficacy of ZIVO’s proprietary active ingredients when applied to real-world poultry production environments.

Catalyzed by encouraging findings from completed studies in avian influenza and coccidiosis, ZIVO has attracted interest from several global animal health companies seeking innovative, non-antibiotic solutions to combat disease transmission. This interest underscores the opportunity for ZIVO’s proprietary algal-derived compounds to play a role in improving poultry health and productivity.

"The University of Delaware is a preeminent institution in animal science research and we look forward to continuing our collaboration to advance understanding of how our active ingredients can combat avian influenza," said John Payne, Chairman and CEO of ZIVO Bioscience. "The interest from leading animal health companies further validates our approach and commitment to delivering sustainable, healthier solutions at cost parity to the poultry industry."

“This newest study represents the next step in what we expect will be a series of studies to thoroughly evaluate the potential of ZIVO's products in various avian influenza applications. By leveraging active components from our proprietary algal cultures in new indications, we aim to develop effective, natural alternatives to traditional treatments, thereby addressing the significant challenges in animal health of cost and drug resistance,” added Mr. Payne.

In the category of ..... I JUST DON'T GET IT .... ZIVO releases news starting a new study with the University of Delaware ...... AFTER F*^&ING HOURS ........ I dunno for what purpose.

https://www.businesswire.com/news/home/20250206639313/en/ZIVO-Bioscience-Plans-New-Study-with-University-of-Delaware-to-Combat-Avian-Influenza-in-Poultry

I really just don't get it at all.
Amigo Mike

Mike- I'm still convinced this 'action' we see on most days in ZIVO is one (or two, at most) parties tossing shares back and forth to "paint" the tape/chart the way they want...creating the illusion of demand/selling, etc on any given day.

Volume is just way too low and daily chart is just too perfect looking to be otherwise imo.

I'm still of the opinion, there will be no guessing as to whether something has truly transpired...as we'll see true, real volume coming into the stock.

LOL.

Bid got dumped on while maintaining $22 offer. I guess folks aren't willing to hold on here.

Amigo Mike

It was on the tape (I saw it too), but perhaps a late print from y'day tape...as OTC does not trade a pre and post market...

Looks like new buy interest today as well. Bids moved up to $21.50 area.
But someone standing in the way at $22 .......

Tic toc ..... tic toc .....

Amigo Mike